Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FY.1.4NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XBB.2.3.5NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XBB.1.9.5NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
FE.1.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XBB.1.16.13NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
FR.1.4NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
GY.2.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XBC.1.6NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
FL.1.4NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
FY.4.1.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
HH.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
GY.7NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
FY.5.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
HH.1.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XBB.1.5.85NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
FU.5NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.503NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.36.31NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.623NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.214.3NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.588NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.210NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
A.28NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.567NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
C.23NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
C.2.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.541NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.36.24NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.1.25NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.189NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.563NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.36.34NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.1.258NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.426NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.399NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.1.337NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.539NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
C.35NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.177.54NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.164NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
KY.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
JN.2.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.1.392NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.377NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
AY.5.3 (Delta)NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BB.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
FY.3.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
HH.7NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XBB.1.22.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
GY.6NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used